Traditional Chinese medicine composition for treating urinary tract inflammations
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
Urinary tract inflammation and composition technology, applied in the field of pharmaceutical preparations, can solve the problems of large side effects and easy recurrence, and achieve the effects of low cost, simple preparation, and mild medicinal properties
Inactive Publication Date: 2014-05-28
赵世明
View PDF1 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, anti-inflammatory drugs are mainly used to treat urinary tract inflammation. Although they hav...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0012] A traditional Chinese medicine composition for treating urinary tract inflammation, wherein the raw materials and weight ratio of the medicine are: Rehmannia glutinosa 20g, Angelica sinensis 15g, Morinda officinalis 12g, Lycium barbarum 15g, Mulberry fruit 20g, Shayuanzi 15g, Raspberry 12g, Cuscuta 15g, Shiwei 12g, Cistanche 15g, Mulberry octopus 10g, Rosa japonica 15g, Gardenia 15g, Chuandongzi 10g, Codonopsis 15g, Ligustrum lucidum 15g, Qumai 10g, Achyranthes bidentata 15g, Papaya 15g, Atractylodes macrocephala 15g, Ejiao 10g, Licorice 10g.
Embodiment 2
[0014] A traditional Chinese medicine composition for treating urinary tract inflammation, wherein the raw materials and weight ratio of the medicine are: Rehmannia glutinosa 15g, Angelica sinensis 25g, Morinda officinalis 5g, Lycium barbarum 20g, Mulberry 10g, Shayuanzi 25g, Raspberry 5g, Dodder 20g, Shiwei 10g, Cistanche 25g, Mulberry octopus 5g, Rosa japonica 20g, Gardenia 10g, Chuandongzi 20g, Codonopsis 5g, Ligustrum lucidum 25g, Qumai 12g, Chuan Achyranthes bidentata 20g, papaya 5g, Atractylodes macrocephala 25g, donkey-hide gelatin 5g, licorice 12g.
Embodiment 3
[0016] A traditional Chinese medicine composition for treating urinary tract inflammation, wherein the raw materials and weight ratio of the medicine are: Rehmannia glutinosa 25g, Angelica sinensis 10g, Morinda officinalis 15g, Lycium barbarum 25g, Mulberry fruit 15g, Azalea 20g, Raspberry 10g, Dodder 25g, Shiwei 5g, Cistanche 10g, Mulberry octopus 20g, Rosa japonica 5g, Gardenia 25g, Chuandongzi 12g, Codonopsis 5g, Ligustrum lucidum 10g, Qumai 15g, Chuan Achyranthes bidentata 5g, Papaya 20g, Atractylodes macrocephala 5g, Ejiao 15g, Licorice 8g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine composition for treating urinary tract inflammations. The composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-30 parts of radix rehmanniae preparata, 5-25 parts of angelica sinensis, 5-20 parts of morinda officinalis, 5-25 parts of medlar, 10-30 parts of mulberries, 5-25 parts of flatstem milkvetch seeds, 5-20 parts of raspberries, 5-25 parts of semen cuscutae, 5-20 parts of pyrrosia lingua, 5-25 parts of cistanche, 5-20 parts of mantis egg-case, 5-25 parts of fructus rosae laevigatae, 5-25 parts of jasmine, 5-20 parts of fructus toosendan, 5-25 parts of codonopsis pilosula, 5-25 parts of glossy privet fruits, 5-20 parts of dianthus superbus, 5-25 parts of medicinal cyathula roots, 5-25 parts of pawpaw, 5-25 parts of rhizoma atractylodis macrocephalae, 5-20 parts of colla corii asini and 5-15 parts of liquorice. The traditional Chinese medicine composition provided by the invention has the functions of enriching yin and nourishing kidney, invigorating spleen and supplementing qi, clearing heat and promoting diuresis and inducing diuresis for treating strangurtia, and is remarkable in curative effect and reliable in effect to treat urinary tract inflammations such as frequent micturition, urgent urination and odynuria caused by deficiency of the kidney and damp heat.
Description
technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating urinary tract inflammation. Background technique [0002] Urinary tract inflammation is a relatively common disease. In outpatient clinics, the incidence of urinary tract inflammation was 2.31% among diseases dominated by urinary tract symptoms. Western medicine believes that urinary tract inflammation is mainly caused by bacterial infection of the urinary system. Any pathogenic bacteria invading the urinary tract can cause urinary tract infection, but the most common pathogenic bacteria are intestinal gram-negative bacilli, among which Escherichia coli Histobacter is the most common, accounting for 80 to 90% of acute urinary tract infections. Bacteria can invade the urinary system through 4 ways: ascending, hematogenous, lymphatic and direct spread. In addition to bacterial factor...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more